These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 10749285)
1. Bcl-2, bcl-x, and bax expression in dysembryoplastic neuroepithelial tumors. Prayson RA Clin Neuropathol; 2000; 19(2):57-62. PubMed ID: 10749285 [TBL] [Abstract][Full Text] [Related]
2. Dysembryoplastic neuroepithelial tumor: a clinicopathologic and immunohistochemical study of 11 tumors including MIB1 immunoreactivity. Prayson RA; Morris HH; Estes ML; Comair YG Clin Neuropathol; 1996; 15(1):47-53. PubMed ID: 8998857 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. Soini Y; Kinnula V; Kaarteenaho-Wiik R; Kurttila E; Linnainmaa K; Pääkkö P Clin Cancer Res; 1999 Nov; 5(11):3508-15. PubMed ID: 10589765 [TBL] [Abstract][Full Text] [Related]
4. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas. Bairey O; Zimra Y; Shaklai M; Okon E; Rabizadeh E Clin Cancer Res; 1999 Oct; 5(10):2860-6. PubMed ID: 10537354 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients. Camilleri-Broët S; Camparo P; Mokhtari K; Hoang-Xuan KH; Martin A; Arborio M; Hauw JJ; Raphaël M Mod Pathol; 2000 Feb; 13(2):158-65. PubMed ID: 10697273 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
8. Dysembryoplastic neuroepithelial tumors and gangliogliomas: clinical results of 52 patients. Ozlen F; Gunduz A; Asan Z; Tanriverdi T; Ozkara C; Yeni N; Yalcinkaya C; Ozyurt E; Uzan M Acta Neurochir (Wien); 2010 Oct; 152(10):1661-71. PubMed ID: 20526635 [TBL] [Abstract][Full Text] [Related]
10. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. de Vicente JC; Olay S; Lequerica-Fernandez P; Sánchez-Mayoral J; Junquera LM; Fresno MF J Oral Pathol Med; 2006 Mar; 35(3):140-5. PubMed ID: 16454809 [TBL] [Abstract][Full Text] [Related]
11. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189 [TBL] [Abstract][Full Text] [Related]
12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
13. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome. Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445 [TBL] [Abstract][Full Text] [Related]
16. Bcl-2 and Bax proteins are increased in neocortical but not in thalamic apoptosis following devascularizing lesion of the cerebral cortex in the rat: an immunohistochemical study. Sulejczak D; Czarkowska-Bauch J; Macias M; Skup M Brain Res; 2004 May; 1006(2):133-49. PubMed ID: 15051517 [TBL] [Abstract][Full Text] [Related]
17. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis. Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins. Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935 [TBL] [Abstract][Full Text] [Related]
19. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x. Pollack A; Cowen D; Troncoso P; Zagars GK; von Eschenbach AC; Meistrich ML; McDonnell T Cancer; 2003 Apr; 97(7):1630-8. PubMed ID: 12655519 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. Kapranos N; Karaiosifidi H; Valavanis C; Kouri E; Vasilaros S Anticancer Res; 1997; 17(4A):2499-505. PubMed ID: 9252670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]